Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

October 31, 2013

Conditions
Kidney Tubular Necrosis, Acute
Interventions
BIOLOGICAL

Multipotent Stromal Cells

Post-operative administration of MSC

BIOLOGICAL

Administration of MSC

Dose escalation protocol

Trial Locations (2)

84124

St Mark's Hospital, Salt Lake City

84157

Intermountain Medical Center, Murray

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Intermountain Health Care, Inc.

OTHER

collaborator

St Mark's Hospital Foundation

OTHER

lead

AlloCure Inc.

INDUSTRY

NCT00733876 - Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery | Biotech Hunter | Biotech Hunter